Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kynex is a brand name associated with two distinct therapeutic agents. Historically, it referred to sulfamethoxypyridazine, a long-acting sulfonamide antibiotic used for bacterial infections such as urinary tract infections and meningococcal meningitis. More recently, the name has been used for sodium hyaluronate (hyaluronic acid) products. In this context, it is a high molecular weight polysaccharide biologic used as a viscosupplement for the treatment of osteoarthritis pain, particularly in the knee, and as an ophthalmic lubricant for dry eye syndrome. Sodium hyaluronate works by restoring the rheological properties of synovial fluid or the tear film, providing lubrication and shock absorption in affected tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kynex.